Product image of Nimbex (Cisatracurium Besilate) supplied by GNH India

Nimbex

Active Ingredient:
Cisatracurium Besilate
Origin:
EU

Nimbex (Cisatracurium Besilate)

Cisatracurium Besilate, the active ingredient in Nimbex, is a non-depolarizing neuromuscular blocking agent presented as an injectable solution for intravenous use. It facilitates endotracheal intubation, provides muscle relaxation during surgery, and serves as an adjunct for mechanical ventilation in adult patients.

GNH India supplies Nimbex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Aspen Pharma Trading Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Cisatracurium Besilate is a non‑depolarizing neuromuscular blocker used in peri‑operative and critical‑care settings.

  • Facilitation of endotracheal intubation: provides rapid, controlled muscle relaxation to allow safe airway placement.
  • Muscle relaxation during surgery: maintains skeletal muscle paralysis throughout general anesthesia.
  • Adjunct for mechanical ventilation: enables synchronized ventilation by preventing spontaneous breathing efforts.

How It Works

  • Cisatracurium Besilate competitively antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, preventing acetylcholine from triggering depolarization of skeletal muscle fibers. This blockade results in dose‑dependent skeletal muscle relaxation without causing initial fasciculations, allowing controlled paralysis during anesthesia and intensive‑care procedures.

Side Effects

Cisatracurium Besilate may be associated with a range of adverse reactions, most of which are related to its pharmacologic action on the neuromuscular junction and cardiovascular system.

Common Side Effects

  • Hypotension: transient drop in blood pressure.
  • Bradycardia: slower than normal heart rate.
  • Flushing: redness of the skin.
  • Bronchospasm: narrowing of the airways.
  • Dry mouth: reduced salivation.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction requiring immediate treatment.
  • Prolonged neuromuscular blockade: extended paralysis beyond the intended period.
  • Cardiac arrest: cessation of heart activity.
  • Severe hypotension: marked drop in blood pressure leading to organ hypoperfusion.

Precautions & Warnings

Cisatracurium Besilate requires careful patient assessment and monitoring due to its potent neuromuscular effects.

  • Renal impairment: monitor dosing as clearance may be reduced.
  • Hepatic impairment: use with caution; altered metabolism may occur.
  • Concurrent use of other neuromuscular blockers: avoid additive paralysis.
  • Patients with myasthenia gravis: increased sensitivity to blockade.
  • Pregnancy: safety not established; weigh risks versus benefits.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Cisatracurium Besilate can interact with several drug classes, influencing the depth and duration of muscle relaxation.

Major Interactions (Avoid)

  • Aminoglycoside antibiotics: potentiate neuromuscular blockade.
  • Lithium: may enhance muscle relaxation and prolong effect.
  • Magnesium sulfate: increased risk of prolonged blockade.

Moderate Interactions (Monitor Closely)

  • Volatile anesthetics: additive effect on muscle relaxation.
  • Opioids: may deepen paralysis when combined.
  • Beta‑adrenergic blockers: may affect hemodynamic stability.

Frequently Asked Questions

Nimbex, containing cisatracurium besilate, is used to facilitate endotracheal intubation, provide skeletal muscle relaxation during surgical procedures, and act as an adjunct to mechanical ventilation in intensive‑care settings. It is administered intravenously by a qualified healthcare professional.

Cisatracurium besilate works by competitively blocking nicotinic acetylcholine receptors at the neuromuscular junction. This prevents acetylcholine from depolarizing the muscle membrane, resulting in dose‑dependent skeletal muscle relaxation without an initial depolarizing phase.

The dose of Nimbex is individualized by the prescribing clinician based on the patient’s weight, clinical condition, and desired depth of paralysis. Dosing regimens are established in accordance with local guidelines and the product’s prescribing information.

Safety data for cisatracurium besilate in pregnancy and lactation are limited. The drug should be used only if the potential benefit justifies any potential risk to the fetus or infant, and decisions should be made by the treating physician.

To order Nimbex, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required), and import documentation.

Nimbex (cisatracurium) is a non‑depolarizing agent that undergoes Hofmann elimination, making its metabolism largely independent of renal or hepatic function. This contrasts with agents like rocuronium, which rely more on hepatic clearance, and may offer advantages in patients with organ dysfunction.

Nimbex should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use and discard any solution that appears discolored or contains particles.

Nimbex is supplied as an injectable solution for intravenous use. It is typically given as a bolus dose for rapid onset, followed by a continuous infusion or repeat bolus doses to maintain the desired level of muscle relaxation, under continuous monitoring.

The most serious risks include prolonged neuromuscular blockade, severe hypotension, anaphylactic reactions, and rare occurrences of cardiac arrest. Continuous neuromuscular monitoring and hemodynamic support are essential during administration.

Nimbex is contraindicated in patients with known hypersensitivity to cisatracurium or any component of the formulation. Caution is advised in individuals with myasthenia gravis, severe hepatic or renal impairment, and in pregnant or breastfeeding women unless clearly indicated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.